Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma

Research output: Contribution to journal › Letter

Original language	English (US)
Pages (from-to)	2735-2736
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	29
Issue number	19
DOIs	https://doi.org/10.1200/JCO.2011.35.8333
State	Published - Jul 1 2011
Externally published	Yes

Cite this

@article{01954d989b7743ba854ae0dce0d6e87b,

title = "Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma",

author = "Sorscher, {Steven M.} and Lockhart, {Albert Craig}",

year = "2011",

month = jul,

day = "1",

doi = "10.1200/JCO.2011.35.8333",

language = "English (US)",

volume = "29",

pages = "2735--2736",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "19",

}

TY - JOUR

T1 - Ras inhibition and the survival benefit favoring zoledronic acid compared with denosumab in patients with multiple myeloma

AU - Sorscher, Steven M.

AU - Lockhart, Albert Craig

PY - 2011/7/1

Y1 - 2011/7/1

UR - http://www.scopus.com/inward/record.url?scp=79960119562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960119562&partnerID=8YFLogxK

U2 - 10.1200/JCO.2011.35.8333

DO - 10.1200/JCO.2011.35.8333

M3 - Letter

C2 - 21646612

AN - SCOPUS:79960119562

VL - 29

SP - 2735

EP - 2736

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 19

ER -